Evaluation of baseline BRAF V600E mutation in circulating tumor DNA and efficacy response from the BEACON study

被引：15

作者：

Kopetz, Scott

Murphy, Danielle A.

Pu, Jie

Yaeger, Rona

Ciardiello, Fortunato

Desai, Jayesh

Van Cutsem, Eric

Wasan, Harpreet Singh

Yoshino, Takayuki

Elez, Elena

Golden, Adele

Zhu, Zhou

Zhang, Xiaosong

Tabernero, Josep

机构：

[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[2] Pfizer, La Jolla, CA USA

[3] Mem Sloan Kettering Canc Ctr, New York, NY USA

[4] Univ Campania Luigi Vanvitelli, Naples, Italy

[5] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia

[6] Univ Hosp Gasthuisberg, Leuven, Belgium

[7] Univ Leuven, Leuven, Belgium

[8] Imperial Coll London, Hammersmith Hosp, London, England

[9] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan

[10] UVic UCC, Vall dHebron Univ Hosp, Barcelona, Spain

[11] UVic UCC, Vall dHebron Inst Oncol VHIO, Barcelona, Spain

[12] Pfizer, Cambridge, MA USA

来源：

关键词：

D O I：

10.1200/JCO.2022.40.4_suppl.162

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

162

引用

页数：3